Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Diabete & Metabolisme|March 1, 1993
Impaired fibrinolytic response to increased thrombin activation in type 1 diabetes mellitus: effects of the glycosaminoglycan sulodexideA Ceriello, A Quatraro, E Marchi, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|August 1, 1986
Antithrombotic effect of OP/LMWH by subcutaneous route in ratsM Fantuz, R Milani, G Andriuoli, et al.
Thrombosis and Haemostasis|February 1, 1995
Desmin 370, a low molecular weight dermatan sulfate, reduces the weight of preformed thrombi in rats made afibrinogenemic by ancrodM Barbanti, F Calanni, E Marchi, et al.
Thrombosis and Haemostasis|August 26, 1998
Prevention and therapy of experimental venous thrombosis in rabbits by desmin 370M Colucci, M R Rossiello, M Barbanti, et al.
Agents and Actions|June 1, 1984
Effect of SAS 650 (Furofenac) on malondialydehyde production by plateletsG P Corbelli, L Stanzani, R Mastacchi, et al.
Diabetes|April 1, 1990
Possible role for increased C4b-binding-protein level in acquired protein S deficiency in type I diabetesA Ceriello, D Giugliano, A Quatraro, et al.
Diabetologia|March 1, 1990
Evidence for a hyperglycaemia-dependent decrease of antithrombin III-thrombin complex formation in humansA Ceriello, D Giugliano, A Quatraro, et al.
Arzneimittel-Forschung|September 1, 1996
A new series of 6-chloro-2,3-dihydro-4(1H)-quinazolinone derivatives as antiemetic and gastrointestinal motility enhancing agentsC Baldazzi, M Barbanti, R Basaglia, et al.
Acta Haematologica|January 1, 1989
Hyperglycemia-conditioned increase in alpha-2-macroglobulin in healthy normal subjects: a phenomenon correlated with deficient antithrombin III activityA Ceriello, A Quatraro, P Dello Russo, et al.
Arzneimittel-Forschung|November 1, 1987
Pharmacokinetics and organ distribution in rats of a low molecular weight heparinS Guizzardi, R Mastacchi, P Govoni, et al.
Pageof 5